Dilemmas in Metastatic Differentiated Thyroid Cancer: To irradiate, medicate, or palliate?

E-ISSN： 0975-7902|8|2|168-171

ISSN： 0975-5039

Source： World Journal of Endocrine Surgery, Vol.8, Iss.2, 2016-05, pp. : 168-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib in metastatic radioactive iodinerefractory differentiated thyroid cancer: A pilot study

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 87-92

Spandidos Publications

Access to resources Recommend Favorite

Is recombinant human TSH as effective as thyroid hormone withdrawal in the detection and treatment of metastatic differentiated thyroid cancer?

By Iervasi Giorgio Bottoni Antonio Filidei Elena

Expert Review of Endocrinology and Metabolism, Vol. 7, Iss. 6, 2012-11 ,pp. : 633-635

Informa Healthcare

Access to resources Recommend Favorite

Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 605-614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multitargeted Kinase Inhibition in Metastatic Differentiated Radioiodine-Refractory Thyroid Cancer: A Look at New Therapeutic Options for a Rare Disease

Oncology Research and Treatment, Vol. 39, Iss. 9, 2016-08 ,pp. : 548-552

Karger

Access to resources Recommend Favorite

The therapeutic management of differentiated thyroid cancer

By Sipos Jennifer A Mazzaferri Ernest L

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2627-2637

Informa Healthcare

Access to resources Recommend Favorite